Li Kang Biomedical Co Ltd

ROCO:6242 (Taiwan)  
NT$ 51.40 (+0.78%) Jun 7
14.50
P/B:
1.88
Market Cap:
NT$ 1.63B ($ 50.52M)
Enterprise V:
NT$ 1.21B ($ 37.34M)
Volume:
10.00K
Avg Vol (2M):
20.43K
Volume:
10.00K
Avg Vol (2M):
20.43K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Li Kang Biomedical Co Ltd ( ROCO:6242 ) from 2003 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Li Kang Biomedical stock (ROCO:6242) PE ratio as of Jun 10 2024 is 14.5. More Details

Li Kang Biomedical Co Ltd (ROCO:6242) PE Ratio (TTM) Chart

To

Li Kang Biomedical Co Ltd (ROCO:6242) PE Ratio (TTM) Historical Data

Total 1216
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Li Kang Biomedical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-10 14.5 2024-04-03 15.2
2024-06-07 14.5 2024-04-02 15.2
2024-06-06 14.4 2024-04-01 15.3
2024-06-05 14.4 2024-03-29 15.2
2024-06-04 14.4 2024-03-28 15.3
2024-06-03 14.5 2024-03-27 13.0
2024-05-31 14.4 2024-03-26 12.9
2024-05-30 14.5 2024-03-25 12.8
2024-05-29 14.4 2024-03-22 12.8
2024-05-28 14.2 2024-03-21 12.8
2024-05-27 14.2 2024-03-20 12.8
2024-05-24 14.3 2024-03-19 12.8
2024-05-23 14.3 2024-03-18 12.9
2024-05-22 14.3 2024-03-15 12.9
2024-05-21 14.4 2024-03-14 12.9
2024-05-20 14.3 2024-03-13 12.9
2024-05-17 14.2 2024-03-12 12.9
2024-05-16 14.3 2024-03-11 13.0
2024-05-15 14.3 2024-03-08 12.9
2024-05-14 14.3 2024-03-07 13.0
2024-05-13 14.3 2024-03-06 13.0
2024-05-10 14.5 2024-03-05 13.0
2024-05-09 14.5 2024-03-04 13.0
2024-05-08 14.6 2024-03-01 13.1
2024-05-07 14.6 2024-02-29 13.3
2024-05-06 14.6 2024-02-28 13.3
2024-05-03 14.6 2024-02-27 13.3
2024-05-02 14.8 2024-02-26 13.3
2024-04-30 14.8 2024-02-23 13.3
2024-04-29 14.9 2024-02-22 13.4
2024-04-26 14.6 2024-02-21 13.4
2024-04-25 14.5 2024-02-20 13.3
2024-04-24 14.4 2024-02-19 13.4
2024-04-23 14.2 2024-02-16 13.1
2024-04-22 14.2 2024-02-15 13.1
2024-04-19 14.3 2024-02-14 13.1
2024-04-18 14.5 2024-02-13 13.1
2024-04-17 14.5 2024-02-12 13.1
2024-04-16 14.4 2024-02-09 13.1
2024-04-15 14.9 2024-02-08 13.1
2024-04-12 15.0 2024-02-07 13.1
2024-04-11 15.0 2024-02-06 13.1
2024-04-10 15.1 2024-02-05 13.1
2024-04-09 15.1 2024-02-02 12.8
2024-04-08 15.0 2024-02-01 12.9

Li Kang Biomedical Co Ltd (ROCO:6242) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Li Kang Biomedical Co Ltd is a Taiwan based company engages in tourism factory businesses, telemarketing, as well as the manufacturing and sales of cosmetics and hygienic drinks.